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Minerals are structural component of body tissues as 
well as involved in various physiological processes like 
cofactors of several enzymes. They also play an 
important role in energy production1. Diabetes mellitus is 
a metabolic syndrome of heterogeneous etiology with the 
common denominator hyperglycaemia due to absolute or 
relative deficiency of insulin 2. Disturbances in trace 
element status and increased oxidative stress in diabetes 
may contribute to insulin resistance and the development 
of diabetes and diabetic complications 3,4 . On the other 
hand, progression of diabetes may also lead to 
perturbation in trace element metabolism and 
homeostasis 5.  
Trace elements like chromium, selenium, magnesium 
and molybdenum have essential role in insulin action 6. 
Zinc, an essential trace element is involved in synthesis, 
storage and secretion of insulin, as well as maintains 
conformational integrity of insulin. Magnesium is an 
essential ion which helps in insulin secretion and also 
acts as critical cofactor of several enzymes in 
carbohydrate metabolism 
7
. Magnesium has been 
reported to be mainly intracellular, and its intracellular 
uptake is stimulated by insulin, although the cellular 
physiology of magnesium metabolism is not fully 
understood 8. Optimum level of chromium aids in binding 
of insulin to cells by increasing insulin receptors and 
there is increased insulin sensitivity, glucose utilization 
and beta cell activity. Reactive oxygen species (ROS) are 
generated when a person is suffering from 
hyperglycemia and copper facilitates production of ROS 
through Fenton reaction 9. In this backdrop our present 
study is designed to observe the serum levels of 
magnesium, zinc and copper in patients suffering from 
type 2 diabetes mellitus.  
MATERIALS & METHODS 
The present study was carried out during 2012 
at BIN and R.G. Kar Medical College, Kolkata in the 
department of Biochemistry. Sixty patients of type 2 
diabetes mellitus without any complication, attending 
Medicine OPD were selected for the study. The patients 
were considered for study at their first visit before 
starting of drug therapy. Forty healthy individuals 
without any disorder were chosen as controls. Informed 
consent was obtained from all the participants of the 
study and the protocol was approved by Institutional 
Ethics Committee. 
ABSTRACT 
Alterations in serum concentrations of several trace elements including copper, zinc, manganese, and the macroelement 
magnesium have been reported to occur in type-2 diabetes mellitus. This study is done to evaluate copper, zinc and magnesium 
status in diabetic and nondiabetic human subjects. In this comparative analysis, the serum concentration of copper, zinc and 
magnesium was estimated in 60 patients with type 2 diabetes mellitus without complication and 40 healthy non-diabetic 
subjects.  The data was analyzed by students’t’ test and Pearson’s correlation coefficient test.Mean serum concentration of 
copper was significantly elevated in diabetic patients compared to control subjects.  Serum zinc levels were significantly low 
(p < 0.001) in diabetic subjects compared to controls . There were no significant differences in serum magnesium between 
groups. Fasting plasma glucose level has significant positive correlation with serum level of copper (r = 0.567; p < 0.001), 
while zinc has negative correlation (r = -0.311; p < 0.047), but there is no significant correlation of plasma glucose level with 
serum magnesium level. Diabetic patients have signiﬁcantly lower mean serum zinc levels and significantly higher serum 
copper concentration compared with healthy controls respectively. Along with antidiabetic therapy, supplementation of zinc 
and magnesium and chelation of copper can reduce complications due to diabetes mellitus.  
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Exclusion criteria: 
Diabetic patients with complication were excluded. 
Patients suffering from coronary heart disease, thyroid 
disorder and renal disorder were also excluded from this 
study. 
Fasting blood samples were collected in sterile, dry and 
acid washed vials. Biochemical parameters, such as 
fasting plasma glucose, serum Copper, Zinc and 
Magnesium were measured using NOVA-SPEC 
spectrophotometer. 
Estimation of Plasma Glucose: 
Plasma glucose estimation was done by Glucose 
Oxidase-Peroxidase method 10. 
Estimation of Serum Copper: 
Colorimetric method was used for the quantitative 
determination of serum copper level 11 
Estimation of Serum Zinc: 
Serum zinc was detected by colorimetric method 12. 
Estimation of Serum Magnesium: 
Serum magnesium was estimated by Calmagite method 
13. 
STATISTICAL ANALYSIS 
Statistical analysis was done by students’t’ test and 
correlation between variables were studied by Pearson’s 
correlation coefficient test. p values less than 0.05 were 
considered significant. The statistical analysis was done 




Table 1: Serum concentrations of Glucose, Copper, Zinc & Magnesium in cases & controls 
 Parameters   N Mean SE P value 
Glucose (mg/dl) Case 60 153.41 10.25 < 0.001 





Case 60 131.79 6.544 < 0.001 
  Control 40 
101.43 3.27 
  
Zinc(µg/dl) Case 60 
65.75 2.760 
< 0.001 
  Control 40 
77.95 2.332 
  
Magnesium(mg/dl) Case 60 
1.94 0.104 
< 0.054 




Table 1 shows that serum copper level was significantly 
elevated in diabetic subject compared to healthy 
individuals, but serum zinc and magnesium level was 
low.  
Table 2: Correlation of Serum Glucose with Copper, 
Zinc & Magnesium 
  r = p 
      
FBS & Cu 0.567 < 0.001 
      
FBS & Zn -0.311 < 0.047 
      
FBS & Mg 0.036 0.425 
    
Fasting plasma glucose level has significant positive 
correlation with serum level of copper (r = 0.567; p < 
0.001), while zinc has negative correlation (r = -0.311; p 
< 0.047), but there is no significant correlation of plasma 
glucose level with serum magnesium level.  
Table 3: Correlation of Serum Copper with Zinc & 
Magnesium 
  r = p 
      
Cu & Mg 0.359 < 0.026 
      
Cu & Zn -0.815 < 0.001 
 
It is further observed that in these patients serum copper 
level has positive correlation with serum magnesium 
level (r = 0.359; p < 0.026), but significant negative 
correlation with serum zinc level (r = -0.815; p < 0.001). 
DISCUSSION 
Direct association of trace element with health and 
disease is already established. Diabetes mellitus, one of 
the commonest diseases of the mankind is linked with 
alteration in mineral metabolism. It is a dilemma whether 
DM and high plasma glucose level affect mineral 
metabolism or alteration in mineral homeostasis 
influence carbohydrate metabolism 14. In our study it was 
observed that serum copper level was elevated in 
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diabetic subject compared to healthy individuals, but 
serum zinc and magnesium level was significantly low. 
Hypercupremia has positive correlation with plasma 
glucose level, while zinc has negative correlation, but 
there is no such correlation with magnesium level. These 
findings corroborate with the study Kaji et al 15. Tanaka 
et al 
16 
reported that oxidative stress in type 2 DM is 
facilitated by hypercupremia as excess copper stimulates 
Fenton reaction. Zinc is essential for assembling insulin 
into structurally stable and functional hexamic structure 
17. Zinc is also related to the synthesis, storage and 
secretion of insulin 6. Moreover zinc is a cofactor of 
superoxide dismutase which has a protective effect on 
pancreas from ROS 18. In hypozincaemia the storage, 
synthesis and function of insulin can be affected. Escobar 
et al in 1995 reported that low level of zinc in diabetes 
mellitus is due to loss of zinc via urine or may be due to 
loss of zinc from cells as glucose is translocated into 
muscle 19. Hence it can be stated low level of zinc can 
affect the function of pancreas and plays an important 
role in pathogenesis of DM. Deficiency of magnesium 
have been implicated in insulin resistance, carbohydrate 
intolerance, dyslipidaemia and complication of DM. 
Thus therapeutic replacement of zinc and magnesium 
and chelating excess copper can delay the development 
of complications from DM. 
CONCLUSION 
It is being observed that there are abnormalities in the 
metabolism of several trace elements in diabetes mellitus 
which play a significant role in pathogenesis and 
progression of the disease. Hypomagnesimia can lead to 
insulin-resistance, abnormalities in carbohydrate and 
lipid metabolism. Along with antidiabetic therapy, 
supplementation of zinc and magnesium and chelation of 
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